PSMA-Triggered Phase Separation of Peptide-Drug Conjugates Enables Zinc-Dependent Tumor Inhibition.

Peptide-drug conjugates (PDC) have emerged as a promising modality for targeted tumor therapy, offering high specificity, and design flexibility. However, the therapeutic efficacy of PDC is often limited by rapid systemic clearance, inadequate contro…

Preview only. Read the full abstract at the source